New ventilation strategy aims to reduce lung damage in severe pneumonia
NCT ID NCT07679802
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests a new way of using a breathing machine (ventilator) called time-controlled adaptive ventilation (TCAV) in people with severe lung injury from pneumonia. The goal is to see if TCAV reduces fluid buildup in the lungs compared to standard ventilation. The trial involves 56 adults in the intensive care unit who need a breathing machine. If TCAV works, it could lead to better outcomes and fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Time-controlled adaptive ventilation (TCAV) using Airway Pressure Release Ventilation mode
- What this could lead to
- If effective, TCAV could offer a simple, low-cost way to reduce lung injury and improve survival in patients with severe respiratory failure.
- What could go wrong
- This is a small pilot study with 56 participants, so results may not apply broadly. The new ventilation method could also cause harm, such as worsening oxygen levels or kidney problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Nancy
Nancy, 54000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell infusion aims to free ARDS patients from ventilators
- Scientists build a biobank to decode ARDS and personalize treatment
- Scientists hunt for hidden ARDS subtypes to crack deadly lung failure
- Simple chest squeeze may replace High-Tech ventilator settings
- Lab study hopes to unlock ARDS treatment using patient blood cells
- New study uses imaging to see how nitric oxide helps ARDS lungs